SVS Share Price Performance
Recent SVS News & Updates
No updates
Svas Biosana S.p.A. Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 1.11
- Gross Margin
- 28.10%
- Net Profit Margin
- 4.80%
- Debt/Equity Ratio
- 105.0%
Svas Biosana S.p.A. Competitors
About SVS
- Founded
- 1972
- Employees
- 327
- CEO
- WebsiteView website
SVAS Biosana S.p.A. engages in the production and marketing of medical devices worldwide. The company offers incontinence aids, traditional dressings, and personal care products for use in incontinence devices, dressings, and personal care product applications. It also offers operating packs, medical devices, infusion and aspiration, linen, advanced dressings, and lubricating gels that are used in haemodynamic, heart surgery, anaesthesia, and critical care applications. In addition, the company provides specialist medical devices for use in oncology, intensive care, chronic illnesses, and surgeries; and medical devices for use in radiology and diagnostic imaging, orthopaedics, cardiology, heart surgery, and critical care applications. SVAS Biosana S.p.A. was founded in 1972 and is based in Somma Vesuviana, Italy.
Italian Market Performance
- 7 Days: 2.0%
- 3 Months: 9.5%
- 1 Year: 21.4%
- Year to Date: 18.7%
Over the last 7 days, the market has risen 2.7%, driven by gains of 5.2% in the Financials sector. In the last year, the market has climbed 20%. Earnings are forecast to grow by 7.2% annually. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading